The University of Vermont Cancer Center welcomed Kathryn P. Lowry, MD, Associate Professor of Radiology at the University of Washington and a collaborator with the Vermont Breast Cancer Surveillance System (VBCSS), as a guest speaker in its CroSSTOC (Cross-disciplinary Seminars on the Science and Treatment of Cancer) seminar series.
Dr. Lowry presented "Who is At High Risk for Breast Cancer? Understanding Strengths and Limitations of Breast Cancer Risk Prediction Models," sharing insights into current approaches for identifying women at elevated risk of breast cancer and discussing the opportunities and limitations of existing risk prediction tools. Dr. Lowry is an expert in artificial intelligence (AI)-based risk prediction algorithms that produce risk scores based on mammography images and gave an update on their development and performance in relation to conventional models based on clinical risk factors. The first FDA-approved AI-based risk prediction tool was just released for commercial use this past month.
The visit also highlighted the longstanding collaborative relationship between UVM researchers and colleagues across the Breast Cancer Surveillance Consortium (BCSC), a research network dedicated to improving the understanding of breast cancer screening, risk assessment, and outcomes. Dr. Lowry has previously worked with the VBCSS to evaluate the performance of supplemental ultrasound screening for women with dense breasts, among numerous other topics. She currently leads an NCI-funded R37 grant that involves collaboration with the VBCSS and other BCSC sites to evaluate the performance of AI-based risk prediction algorithms in clinical breast imaging settings. Through these collaborations, researchers continue to advance evidence that informs breast cancer prevention, detection, and patient care.